Loss-of-Function Mutations of BCOR Are an Independent Marker of Adverse Outcomes in Intensively Treated Patients with Acute Myeloid Leukemia.
Cancers (Basel)
; 13(9)2021 Apr 26.
Article
in En
| MEDLINE
| ID: mdl-33926021
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Cancers (Basel)
Year:
2021
Document type:
Article
Affiliation country:
Germany
Country of publication:
Switzerland